A
$ Value
$0
Shares
31,750
Price
$0
Filed
Apr 2
Insider
Name
Simon Amy
Title
Chief Medical Officer
CIK
0001963879
Roles
Officer
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
109,114
Footnotes
Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.
Filing Info
Simon Amy's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | BEAM | ▼ | $165K |
| 2026-03-31 | BEAM | A | $0 |
| 2025-07-03 | BEAM | ▼ | $18K |
| 2025-07-01 | BEAM | ▼ | $6K |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $1.9M | 2026-04-01 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Emany Sravan Kumar
Chief Financial Officer
|
— | — | 2026-03-31 |
|
Bellon Christine
Chief Legal Officer
|
— | $146K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | $80K | 2026-04-01 |